Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Buxhofer-Ausch, V; Steurer, M; Sormann, S; Schloegl, E; Schimetta, W; Gisslinger, B; Schalling, M; Krauth, MT; Thiele, J; Ruckser, R; Gastl, G; Gisslinger, H.
Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia.
EUR J HAEMATOL. 2018; 74(9):
Doi: 10.1111/ejh.13070
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Sormann Siegfried
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Risk of thrombosis is significantly enhanced by both elevated platelet (PLT) and white blood cell (WBC) counts according to a retrospective analysis of a large anagrelide registry in thrombocythemic MPN patients. We were interested in the impact of elevated WBC counts on thrombosis risk in patients where PLT counts were reduced below the calculated cutoff of 574.5 G/L by treatment with anagrelide. Cox regression analysis and Kaplan-Meier plot were applied on all patients in the registry with optimized PLT counts. Using the calculated cutoff of 9.66 G/L for WBC, Cox regression analysis revealed a clear influence of elevated WBC counts on the occurrence of a major thrombotic event (P = .012). A Kaplan-Meier plot revealed a markedly shorter time to a major thrombotic event for patients with WBC counts above the cutoff (P = .001). These data suggest that additional correction of elevated WBC counts is mandatory in patients with optimally managed PLT counts to reduce thrombotic risk. This study is the first investigation in a prospectively observed large patient cohort which was treated homogenously allowing for evaluation of single parameters for an effect on thrombophilia. © 2018 The Authors. European Journal of Haematology Published by John Wiley & Sons Ltd.
- Find related publications in this database (Keywords)
- essential thrombocythemia
- thrombotic risk
- white blood cells